Skip to main content

Acne

  • Chapter
  • First Online:
Update in Cosmetic Dermatology

Abstract

Acne is a chronic inflammatory, exclusively human disease of the pilosebaceous unit, mostly affecting the sebaceous gland follicles – usually referred to as sebaceous follicles – located on the face, chest, shoulders, and back, where they are most common.

Acne is the most common disease affecting all ages and ethnic groups and is the leading dermatologic diagnosis with 10.2 million diagnoses. Acne is considered a problem that occurs in adolescence, but the prevalence of adult acne is 3 % in men and between 11 and 12 % in women.

We can distinguish different types of acne: acne neonatorum and infantile, acne vulgaris (teenage acne), adult acne, acne conglobata, acne inversa, and acne fulminans.

Diet, weight loss, sunlight, and cosmetics/drugs are differently related to acne symptoms.

The treatment of acne is based on different approaches such as cosmetological and cleansing agents, moisturizing agents, sebum regulators, keratolytics, and photoprotection to support medical treatment based on topical (retinoids, antibiotics, alpha hydroxy acids, and chemical peels) and systemic medical treatment (oral antibiotics, oral isotretinoin, hormonal therapy).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aristotle (1605) Historia animalium, 556b, 29; Problemata, 36, 3; in edn. Casaubon p 654B, 639E

    Google Scholar 

  2. Hippocritus (1826) De Morbis Vulgaribus; in edn. Loeb Classical Library, Hippocrates, 1, 188. De Internus Affectionibus; in edn. Kuhn Medicorum Grecorum Opera, 22, 427

    Google Scholar 

  3. Pliny (1897) Historia naturalis, Lib. 23; in edn. Mayhoff, Lipsiae 4, p 7, 8, 27, 28

    Google Scholar 

  4. Celsus (1831) De Medicina, Lib. 6, Cap. 5; Lugduni p. 552; in edn. Lee, London, p. 136

    Google Scholar 

  5. Niemeier V, Kupfer J, Gieler U (2006) Acne vulgaris – psychosomatic aspects. Dtsch Dermatol Ges 4(12):1027–1036

    Article  Google Scholar 

  6. Goulden V, Stables GI, Cunliffe WJ (1999) Prevalence of facial acne in adults. J Am Acad Dermatol 41:577–580

    PubMed  CAS  Google Scholar 

  7. White GM (1998) Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol 39:S34–S37

    Article  PubMed  CAS  Google Scholar 

  8. Katsambas AD, Katoulis AC, Stavropoulos P (1999) Acne neonatorum: a study of 22 cases. Int J Dermatol 38(2):128–130

    Article  PubMed  CAS  Google Scholar 

  9. Van Praag MC, Van Rooij RW, Folkers E et al (1997) Diagnosis and treatment of pustular disorders in the neonate. Pediatr Dermatol 14(2):131–143

    Article  PubMed  Google Scholar 

  10. Barnes CJ, Eichenfield LF, Lee J et al (2005) A practical approach for the use of oral isotretinoin for infantile acne. Pediatr Dermatol 22(2):166–169

    Article  PubMed  Google Scholar 

  11. Sarazin F, Dompmartin A, Nivot S et al (2004) Treatment of an infantile acne with oral isotretinoin. Eur J Dermatol 14(1):71–72

    PubMed  CAS  Google Scholar 

  12. Capitanio B, Sinagra JL, Ottaviani M et al (2007) ‘Smoker’s acne’: a new clinical entity? Br J Dermatol 157:1070–1071

    Article  PubMed  CAS  Google Scholar 

  13. Schäfer T, Nienhaus A, Vieluf D et al (2001) Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 145:100–104

    Article  PubMed  Google Scholar 

  14. Gary M, White MD (1998) Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol 39(2 Pt 3):S34–S37

    Google Scholar 

  15. Church JM, Fazio VW, Lavery IC et al (1993) The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn’s disease. Int J Colorectal Dis 8(3):117–119

    Article  PubMed  CAS  Google Scholar 

  16. Anderson P (1971) Foods as a cause of acne. Am J Fam Pract 3:102–103

    CAS  Google Scholar 

  17. Kalminster LH (1978) Acne, what friends or patients ask about. J Am Med Assoc 239:2171–2172

    Article  Google Scholar 

  18. Rasmussen J (1977) Diet and acne. Int J Dermatol 16:488–492

    Article  PubMed  CAS  Google Scholar 

  19. Aizawa H, Niimura M (1995) Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol 22:249–252

    PubMed  CAS  Google Scholar 

  20. Cordain L, Eades MR, Eades MD (2003) Hyperinsulinemic diseases of civilization: more than just Syndrome X. Comp Biochem Physiol A Mol Integr Physiol 136:95–112

    Article  PubMed  Google Scholar 

  21. Melnik B (2009) Milk consumption: aggravating factor of acne and promoter of chronic diseases of Western societies. J Dtsch Dermatol Ges 7(4):364–370

    PubMed  Google Scholar 

  22. Del Prete M, Mauriello MC et al (2012) Insulin resistance and acne: a new risk factor for men? Endocrine

    Google Scholar 

  23. Gfesser M, Worret WI (1996) Seasonal variations in the severity of acne vulgaris. Int J Dermatol 35:116–117

    Article  PubMed  CAS  Google Scholar 

  24. Allen HB, LoPresti PJ (1980) Acne vulgaris aggravated by sunlight. Cutis 26:254–256

    PubMed  CAS  Google Scholar 

  25. Papageorgiou P, Katsambas A, Chu A (2000) Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol 142:973–978

    Article  PubMed  CAS  Google Scholar 

  26. Kawada A, Aragane Y, Kameyama H et al (2002) Acne phototherapy with a high intensity, enhanced, narrow band, blue light source: an open study and in vitro investigation. J Dermatol Sci 30:129–135

    Article  PubMed  Google Scholar 

  27. Hongcharu W, Taylor CR, Chang Y et al (2000) Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 115:183–192

    Article  PubMed  CAS  Google Scholar 

  28. Fabbrocini G, Cacciapuoti S et al (2009) The effect of ALA PDT on microcomedons and macrocomedons. Dermatology 219(4):322–328

    Google Scholar 

  29. Fulton JE Jr, Pay SR, Fulton JE (1984) Comedogenicity of current therapeutic products, cosmetics, and ingredients in the rabbit ear. J Am Acad Dermatol 10:96–105

    Article  PubMed  Google Scholar 

  30. Levy SB (1984) Comedogenicity of cosmetics. J Am Acad Dermatol 10:1072

    Article  PubMed  CAS  Google Scholar 

  31. Fulton JE Jr, Bradley S, Aqundez A et al (1976) Non-comedogenic cosmetics. Cutis 17:344–345, 349–51

    PubMed  Google Scholar 

  32. Norris JF, Cunliffe WJ (1988) A histological and immunocytochemical study of early acne lesions. Br J Dermatol 118:651–659

    Google Scholar 

  33. Jeremy AHT, Holland DB, Roberts SG et al (2003) Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 121:20–27

    Article  PubMed  CAS  Google Scholar 

  34. Zouboulis CC (2001) Is acne vulgaris a genuine inflammatory disease? Dermatology 203:277–279

    Article  PubMed  CAS  Google Scholar 

  35. Walton S, Wyatt EH, Cunliffe WJ (1988) Genetic control of sebum excretion and acne – a twin study. Br J Dermatol 118(3):393–396

    Article  PubMed  CAS  Google Scholar 

  36. Bekaert C, Song M, Delvigne A (1998) Acne neonatorum and familial hyperandrogenism. Dermatology 196:453–454

    Article  PubMed  CAS  Google Scholar 

  37. Ostlere LS, Rumsby G, Holownia P et al (1998) Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne. Clin Endocrinol 48:209–215

    Google Scholar 

  38. Pochi PE, Strauss JS (1969) Sebaceous gland response in man to the administration of testosterone, delta-4-androstenedione, and dehydroisoandrosterone. J Invest Dermatol 52:32–36

    Google Scholar 

  39. Cunliffe W, Forster R (1987) Androgen control of the pilosebaceous duct? Br J Dermatol 116:449

    Google Scholar 

  40. Thiboutot D, Knaggs H, Gilliland K et al (1998) Activity of 5α reductase and 17 β hydroxysteroid dehydrogenase in the infrainfundibulum of subjects with and without acne vulgaris. Dermatology 196:38–42

    Article  PubMed  CAS  Google Scholar 

  41. Toyoda M, Nakamura M, Makino T et al (2002) Sebaceous glands in acne patients express high levels of neutral endopeptidase. Exp Dermatol 11:241–247

    Article  PubMed  CAS  Google Scholar 

  42. Draelos ZD, Matsubara A, Smiles K (2006) The effect of 2 % niacinamide on facial sebum production. J Cosmet Laser Ther 8(2):96–101

    Article  PubMed  Google Scholar 

  43. Bibi Nitzan Y, Cohen AD (2006) Zinc in skin pathology and care. J Dermatolog Treat 17(4):205–210

    Article  PubMed  Google Scholar 

  44. Pavicic T, Wollenweber U, Farwick M et al (2007) Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. Int J Cosmet Sci 29(3):181–190

    Article  PubMed  CAS  Google Scholar 

  45. Taglietti M, Hawkins CN, Rao J (2008) Novel topical drug delivery systems and their potential use in acne vulgaris. Skin Therapy Lett 13(5):6–8

    PubMed  CAS  Google Scholar 

  46. Cotellessa C, Manunta T, Ghersetich I et al (2004) The use of pyruvic acid in the treatment of acne. J Eur Acad Dermatol Venereol 18(3):275–278

    Article  PubMed  CAS  Google Scholar 

  47. Bari AU, Iqbal Z, Rahman SB (2007) Superficial chemical peeling with salicylic acid in facial dermatoses. J Coll Physicians Surg Pak 17(4):187–190

    PubMed  Google Scholar 

  48. Thielitz A, Gollnick H (2008) Topical retinoids in acne vulgaris: update on efficacy and safety. Am J Clin Dermatol 9(6):369–381

    Article  PubMed  Google Scholar 

  49. Adişen E, Kaymak Y, Gurer MA (2008) Topical tetracycline in the treatment of acne vulgaris. J Drugs Dermatol 7(10):953–955

    PubMed  Google Scholar 

  50. Fabbrocini G, Annunziata MC, D’Arco V et al (2010) Acne scars: pathogenesis, classification and treatment. Dermatology Research and Practice article ID 893080, 13 pages

    Article  PubMed  CAS  Google Scholar 

  51. Fabbrocini G, De Padova MP, Tosti A (2009) Chemical peels: what’s new and what isn’t new but still works well. Facial Plastic Surgery 25(5):329–336

    Google Scholar 

  52. Rayner VL (1995) Camouflage therapy. Dermatol Clin 13(2):467–472

    PubMed  CAS  Google Scholar 

  53. Ochsendorf F (2006) Systemic antibiotic therapy of acne vulgaris. J Dtsch Dermatol Ges 4(10):828–841

    Article  PubMed  Google Scholar 

  54. Bener A, Lestringant GG, Ehlayel MS et al (2009) Treatment outcome of acne vulgaris with oral isotretinoin. J Coll Physicians Surg Pak 19(1):49–51

    PubMed  Google Scholar 

  55. George R, Clarke S, Thiboutot D (2008) Hormonal therapy for acne. Semin Cutan Med Surg 27(3):188–196

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriella Fabbrocini .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fabbrocini, G., De Padova, M.P. (2013). Acne. In: Tosti, A., Hexsel, D. (eds) Update in Cosmetic Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-34029-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-34029-1_3

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-34028-4

  • Online ISBN: 978-3-642-34029-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics